SCHEMBL24307262

SCHEMBL24307262

Cc1ccc2c(c1)NC(=O)C1(CCCCC1)O2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP12 P39900 1/20 0.49
▸ KDM4E B2RXH2 3/20 0.47
▸ HTT P42858 1/20 0.47
▸ ATM Q13315 1/20 0.47
▸ BRD4 O60885 1/20 0.44
▸ CREBBP Q92793 1/20 0.44
▸ POLB P06746 3/20 0.38
▸ THRB P10828 1/20 0.38
▸ GAA P10253 2/20 0.37
▸ ALDH1A1 P00352 2/20 0.37
▸ MAPT P10636 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ CHEK1 O14757 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24307261 0.98 MMP12 (0.50) MMP12KDM4EHTTATMBRD4
SCHEMBL24306751 0.95 MMP12 (0.50) MMP12KDM4EHTTATMBRD4
SCHEMBL13090980 0.92 MMP12 (0.53) MMP12KDM4EHTTATMBRD4
SCHEMBL26770935 0.88 KDM4E (0.43) MMP12KDM4EHTTATMBRD4
SCHEMBL26771787 0.87 MMP12 (0.48) MMP12KDM4EHTTATMBRD4
SCHEMBL3932411 0.87 MMP12 (0.48) MMP12KDM4EHTTATMBRD4
SCHEMBL26766724 0.83 MMP12 (0.50) MMP12KDM4EHTTATMBRD4
SCHEMBL26766745 0.83 MMP12 (0.50) MMP12KDM4EHTTATMBRD4
SCHEMBL26766721 0.82 MMP12 (0.49) MMP12KDM4EHTTATMBRD4
SCHEMBL25936933 0.81 MMP12 (0.46) MMP12KDM4EHTTATMBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-11-16 — — US disclosed
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF MEDSHINE DISCOVERY INC. (CN) 2023-11-16 — — US disclosed
EP-4219461-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF Medshine Discovery Inc. (CN) 2023-08-02 — — EP disclosed
WO-2022063094-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF 南京明德新药研发有限公司 2022-03-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365558-A1 TETRAHYDROISOQUINOLINE DERIVATIVE AND USE THEREOF CYP3A7, UGT2B7, SFPQ MMP12 4524/4885KDM4E 2152/4885HTT 1404/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback